CRISPR Therapeutics AG — insider transactions
5 transactions on record · CIK 1674416
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$1.2M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$780.9K
2026-09-17
Director share, 12m
100.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
-$1.2M
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 | 2025-08-06 | 411 | Behbahani Ali | Director | Other acquisition or disposition | 60 | $0.00 | — | filing |
| 2026-09-21 | 2026-09-17 | 4 | Behbahani Ali | Director | Exercise of derivative | 30,000 | $0.00 | — | filing |
| 2026-09-21 | 2026-09-17 | 4 | Behbahani Ali | Director | Open market sale | 13,679 | $57.09 | $780.9K | filing |
| 2026-09-21 | 2025-08-06 | 411 | Behbahani Ali | Director | Other acquisition or disposition | 15 | $0.00 | — | filing |
| 2026-09-21 | 2026-09-17 | 4 | Behbahani Ali | Director | Exercise of derivative | 30,000 | $14.00 | $420K | filing |